Pricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. Pretax margin (%)

JMS CO.,LTD.【JP:7702】

Market cap
¥10.7B
P/E ratio
-13.3x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 20250.7+231.83%
Mar 31, 20240.2-75.84%
Mar 31, 20230.9-52.51%
Mar 31, 20221.9-44.63%
Mar 31, 20213.5-23.37%
Mar 31, 20204.6+74.26%
Mar 31, 20192.6+80.45%
Mar 31, 20181.5-44.43%
Mar 31, 20172.6+20.19%
Mar 31, 20162.2+222.64%
Mar 31, 20150.7-69.45%
Mar 31, 20142.2-42.45%
Mar 31, 20133.8+29.78%
Mar 31, 20123

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)